These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29735567)

  • 1. Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis.
    Stott KE; Beardsley J; Whalley S; Kibengo FM; Mai NTH; Tùng NLN; Cuc NTK; Kolamunnage-Dona R; Hope W; Day J
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis.
    Stott KE; Beardsley J; Kolamunnage-Dona R; Castelazo AS; Kibengo FM; Mai NTH; Tùng NLN; Cuc NTK; Day J; Hope W
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days.
    Livermore J; Howard SJ; Sharp AD; Goodwin J; Gregson L; Felton T; Schwartz JA; Walker C; Moser B; Müller W; Harrison TS; Perfect JR; Hope WW
    mBio; 2014 Jan; 5(1):e00725-13. PubMed ID: 24473125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by
    Le T; Ly VT; Thu NTM; Nguyen A; Thanh NT; Chau NVV; Thwaites G; Perfect J; Kolamunnage-Dona R; Hope W
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30420478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis.
    Lestner JM; Howard SJ; Goodwin J; Gregson L; Majithiya J; Walsh TJ; Jensen GM; Hope WW
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3432-41. PubMed ID: 20439615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits.
    Groll AH; Mickiene D; Petraitis V; Petraitiene R; Alfaro RM; King C; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3917-25. PubMed ID: 14638502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis.
    Stott KE; Moyo M; Ahmadu A; Kajanga C; Gondwe E; Chimang'anga W; Chasweka M; Leeme TB; Molefi M; Chofle A; Bidwell G; Changalucha J; Unsworth J; Jimenez-Valverde A; Lawrence DS; Mwandumba HC; Lalloo DG; Harrison TS; Jarvis JN; Hope W; Märtson AG
    J Antimicrob Chemother; 2022 Dec; 78(1):276-283. PubMed ID: 36411251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous infusion of amphotericin B deoxycholate in the treatment of cryptococcal meningoencephalitis: analysis of safety and fungicidal activity.
    Falci DR; Lunardi LW; Ramos CG; Bay MB; Aquino VR; Goldani LZ
    Clin Infect Dis; 2010 Mar; 50(5):e26-9. PubMed ID: 20121575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis.
    Joly V; Aubry P; Ndayiragide A; Carrière I; Kawa E; Mlika-Cabanne N; Aboulker JP; Coulaud JP; Larouze B; Yeni P
    Clin Infect Dis; 1996 Sep; 23(3):556-62. PubMed ID: 8879780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis.
    Alhadab AA; Rhein J; Tugume L; Musubire A; Williams DA; Abassi M; Nicol MR; Meya DB; Boulware DR; Brundage RC;
    J Pharmacokinet Pharmacodyn; 2019 Dec; 46(6):565-576. PubMed ID: 31584146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
    Manosuthi W; Chetchotisakd P; Nolen TL; Wallace D; Sungkanuparph S; Anekthananon T; Supparatpinyo K; Pappas PG; Larsen RA; Filler SG; Andes D;
    HIV Med; 2010 Apr; 11(4):276-81. PubMed ID: 20002501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitis.
    Stott KE; Mohabir JT; Bowers K; Tenor JL; Toffaletti DL; Unsworth J; Jimenez-Valverde A; Ahmadu A; Moyo M; Gondwe E; Chimang'anga W; Chasweka M; Lawrence DS; Jarvis JN; Harrison T; Hope W; Lalloo DG; Mwandumba HC; Perfect JR; Cuomo CA;
    mBio; 2024 Oct; 15(10):e0159224. PubMed ID: 39189739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis.
    Wiederhold NP; Tam VH; Chi J; Prince RA; Kontoyiannis DP; Lewis RE
    Antimicrob Agents Chemother; 2006 Feb; 50(2):469-73. PubMed ID: 16436698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
    Vidal JE; de Albuquerque Moraes C; de Siqueira REB; Miranda NFB; Marcusso R; Boulware DR; de Oliveira ACP
    Mycopathologia; 2021 Mar; 186(1):93-102. PubMed ID: 33258083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis.
    Lestner J; McEntee L; Johnson A; Livermore J; Whalley S; Schwartz J; Perfect JR; Harrison T; Hope W
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of amphotericin B deoxycholate, amphotericin B lipid complex, and liposomal amphotericin B against Aspergillus fumigatus.
    Al-Nakeeb Z; Petraitis V; Goodwin J; Petraitiene R; Walsh TJ; Hope WW
    Antimicrob Agents Chemother; 2015 May; 59(5):2735-45. PubMed ID: 25712363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
    Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
    J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
    Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ
    Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
    Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
    Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.